{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:26:42Z","timestamp":1787671602288,"version":"build-2736575974"},"reference-count":63,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>\n                    Chronic subdural hematoma (cSDH) is among the most common neurosurgical conditions in adults, with incidence rising steadily in aging populations and with increasing antithrombotic drug use. Burr-hole drainage remains the standard treatment for symptomatic cSDH; however, postoperative recurrence rates range from 8 to 30%. Middle meningeal artery embolization (MMAE) targets the pathological blood supply of the dural neomembrane, intervening at the biological source of hematoma progression and representing a fundamental shift in cSDH management. Between 2024 and 2025, four landmark randomized controlled trials (RCTs)\u2014EMBOLISE, STEM, MAGIC-MT, and EMPROTECT\u2014were published. Their conclusions diverge: EMBOLISE and STEM demonstrated that MMAE significantly reduced treatment failure, whereas MAGIC-MT (\n                    <jats:italic>p<\/jats:italic>\n                    \u202f=\u202f0.10) and EMPROTECT (\n                    <jats:italic>p<\/jats:italic>\n                    \u202f=\u202f0.13) did not reach statistical significance on their primary endpoints, despite point estimates consistently favoring MMAE. Unlike published meta-analyses that address the question of whether MMAE is effective overall by pooling effect sizes, this review systematically examines potential sources of heterogeneity across the four RCTs\u2014including primary endpoint definitions, patient population characteristics, embolic materials and technical strategies, the differential impact of open-label design on bias, and embolization timing. Throughout the manuscript, we distinguish three levels of evidence: conclusions directly supported by randomized data (Level A), inferences derived from non-randomized subgroup or indirect comparisons (Level B), and hypotheses grounded in biological reasoning (Level C). On this basis, we propose a multidimensional patient stratification framework incorporating age, antithrombotic status, angiographic classification, and hematoma characteristics, with each recommendation explicitly graded by level of evidence. We emphasize that this framework has not been prospectively validated and is intended exclusively to generate hypotheses for future clinical research, not to serve as a treatment guideline. We further delineate the current clinical indications for MMAE, provide a systematic summary of its complications and safety profile, and identify critical future directions including individual patient data meta-analysis, standardized outcome definitions, and prospective biomarker- and imaging-based validation studies.\n                  <\/jats:p>","DOI":"10.3389\/fneur.2026.1929416","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:46:27Z","timestamp":1787669187000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Middle meningeal artery embolization for chronic subdural hematoma: Interpreting divergent randomized evidence and guiding patient selection"],"prefix":"10.3389","volume":"17","author":[{"given":"Dongfang","family":"Yang","sequence":"first","affiliation":[{"name":"The Second Affiliated Hospital of Naval Medical University (Shanghai Changzheng Hospital)","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibin","family":"Zhang","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Inner Mongolia Medical University","place":["Hohhot, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Xia","sequence":"additional","affiliation":[{"name":"Central Hospital of Dalian University of Technology (Dalian Municipal Central Hospital)","place":["Dalian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoling","family":"Liu","sequence":"additional","affiliation":[{"name":"Central Hospital of Dalian University of Technology (Dalian Municipal Central Hospital)","place":["Dalian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Li","sequence":"additional","affiliation":[{"name":"Central Hospital of Dalian University of Technology (Dalian Municipal Central Hospital)","place":["Dalian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ncl.2024.07.003","article-title":"Contemporary management of subdural hematoma","volume":"43","author":"Naylor","year":"2025","journal-title":"Neurol Clin"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.nec.2024.08.006","article-title":"Middle meningeal artery embolization for subdural hematoma","volume":"36","author":"Chen","year":"2025","journal-title":"Neurosurg Clin N Am"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"afad240","DOI":"10.1093\/ageing\/afad240","article-title":"New horizons in subdural haematoma","volume":"52","author":"Rickard","year":"2023","journal-title":"Age Ageing"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1007\/s10143-025-03743-3","article-title":"Middle meningeal artery embolization for chronic subdural hematoma in octogenarians and nonagenarians: an individual patient pooled meta-analysis","volume":"48","author":"Kasem","year":"2025","journal-title":"Neurosurg Rev"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"123541","DOI":"10.1016\/j.wneu.2024.10.094","article-title":"Complications of middle meningeal artery embolization: a systematic review and meta-analysis","volume":"194","author":"Shafi","year":"2025","journal-title":"World Neurosurg"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1086645","DOI":"10.3389\/fneur.2023.1086645","article-title":"Surgical techniques for evacuation of chronic subdural hematoma: a mini-review","volume":"14","author":"Rodriguez","year":"2023","journal-title":"Front Neurol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2176\/jns-nmc.2022-0207","article-title":"Chronic subdural hematoma\u2014evolution of etiology and surgical treatment","volume":"63","author":"Uno","year":"2023","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"17562864261435399","DOI":"10.1177\/17562864261435399","article-title":"Pathophysiology of chronic subdural hematoma\u2014new insights","volume":"19","author":"Trieu","year":"2026","journal-title":"Ther Adv Neurol Disord"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12974-017-0881-y","article-title":"Pathophysiology of chronic subdural haematoma: inflammation, angiogenesis and implications for pharmacotherapy","volume":"14","author":"Edlmann","year":"2017","journal-title":"J Neuroinflammation"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1694048","DOI":"10.3389\/fsurg.2025.1694048","article-title":"The subdural membrane: unraveling the pathophysiology and treatment of chronic subdural hematoma","volume":"12","author":"Arunachalam Sakthiyendran","year":"2025","journal-title":"Front Surg"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"110783","DOI":"10.1016\/j.jocn.2024.110783","article-title":"Middle meningeal artery embolization following surgical evacuation of symptomatic chronic subdural hematoma improves outcomes, interim results of a prospective randomized trial","volume":"128","author":"Debs","year":"2024","journal-title":"J Clin Neurosci"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/s10143-023-02175-1","article-title":"Risk factors for recurrence of chronic subdural hematoma after surgical evacuation: a systematic review and meta-analysis","volume":"46","author":"Khoshnevisan","year":"2023","journal-title":"Neurosurg Rev"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00701-025-06600-w","article-title":"Can antithrombotic therapy be safely resumed after middle meningeal artery embolization with or without surgery for chronic subdural hematoma? A systematic review and meta-analysis","volume":"167","author":"Kasem","year":"2025","journal-title":"Acta Neurochir"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1001\/jama.2017.0639","article-title":"Association of antithrombotic drug use with subdural hematoma risk","volume":"317","author":"Gaist","year":"2017","journal-title":"JAMA"},{"key":"ref15","first-page":"261","article-title":"Middle meningeal artery embolization for chronic subdural hematoma","volume":"28","author":"Mandai","year":"2000","journal-title":"No Shinkei Geka"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.surneu.2008.01.023","article-title":"Role of angiogenic growth factors and inflammatory cytokine on recurrence of chronic subdural hematoma","volume":"71","author":"Hong","year":"2009","journal-title":"Surg Neurol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1227\/ons.0000000000000656","article-title":"Middle meningeal artery embolization for chronic subdural hematoma: a review","volume":"24","author":"Tonetti","year":"2023","journal-title":"Oper Neurosurg"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e000490","DOI":"10.1161\/SVIN.122.000490","article-title":"Middle meningeal artery embolization to treat chronic subdural hematoma","volume":"3","author":"Rudy","year":"2022","journal-title":"Stroke Vasc Interv Neurol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"e230158","DOI":"10.1148\/rg.230158","article-title":"Middle meningeal artery embolization for management of chronic subdural hematoma","volume":"44","author":"Schmolling","year":"2024","journal-title":"Radiographics"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1093\/neuros\/nyaa379","article-title":"Middle meningeal artery embolization for chronic subdural hematoma: a multi-center experience of 154 consecutive embolizations","volume":"88","author":"Kan","year":"2021","journal-title":"Neurosurgery"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1136\/neurintsurg-2021-017352","article-title":"Middle meningeal artery embolization for chronic subdural hematoma: a systematic review and meta-analysis","volume":"13","author":"Ironside","year":"2021","journal-title":"J Neurointerv Surg"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.wneu.2018.11.167","article-title":"Middle meningeal artery embolization for chronic subdural hematoma: meta-analysis and systematic review","volume":"122","author":"Srivatsan","year":"2019","journal-title":"World Neurosurg"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.wneu.2019.02.230","article-title":"Safety and effectiveness of embolization for chronic subdural hematoma: systematic review and case series","volume":"126","author":"Waqas","year":"2019","journal-title":"World Neurosurg"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s00701-019-04161-3","article-title":"Efficacy and safety of middle meningeal artery embolization in the management of refractory or chronic subdural hematomas: a systematic review and meta-analysis","volume":"162","author":"Jumah","year":"2020","journal-title":"Acta Neurochir"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1056\/NEJMoa2313477","article-title":"Adjunctive middle meningeal artery embolization for subdural hematoma","volume":"391","author":"Davies","year":"2024","journal-title":"N Engl J Med"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1056\/NEJMoa2401201","article-title":"Middle meningeal artery embolization for nonacute subdural hematoma","volume":"391","author":"Liu","year":"2024","journal-title":"N Engl J Med"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1056\/NEJMoa2409845","article-title":"Embolization of the middle meningeal artery for chronic subdural hematoma","volume":"392","author":"Fiorella","year":"2025","journal-title":"N Engl J Med"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1001\/jama.2025.7583","article-title":"Meningeal embolization for preventing chronic subdural hematoma recurrence after surgery: the EMPROTECT randomized clinical trial","volume":"334","author":"Shotar","year":"2025","journal-title":"JAMA"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1177\/15910199241231592","article-title":"Embolization of middle meningeal artery for chronic subdural hematoma: do we have sufficient evidence?","volume":"31","author":"Shankar","year":"2025","journal-title":"Interv Neuroradiol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s00701-025-06587-4","article-title":"Middle meningeal artery embolization for chronic subdural hematoma: meta-analysis of three randomized controlled trials and review of ongoing trials","volume":"167","author":"Gillespie","year":"2025","journal-title":"Acta Neurochir"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1007\/s10143-025-03464-7","article-title":"Middle meningeal artery embolization for chronic subdural hematoma: a meta-analysis of randomized controlled trials with trial sequential analysis","volume":"48","author":"de Almeida Monteiro","year":"2025","journal-title":"Neurosurg Rev"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"123469","DOI":"10.1016\/j.jns.2025.123469","article-title":"Adjunctive middle meningeal artery embolization for chronic subdural hematoma: a systematic review and meta-analysis of clinical trials","volume":"472","author":"Elfil","year":"2025","journal-title":"J Neurol Sci"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s00415-025-13029-9","article-title":"Efficacy and safety of middle meningeal artery embolization for nonacute subdural hematoma","volume":"272","author":"Nie","year":"2025","journal-title":"J Neurol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"2862","DOI":"10.3390\/jcm14092862","article-title":"Embolization of middle meningeal artery in patients with chronic subdural hematoma: a systematic review and meta-analysis of randomized-controlled clinical trials","volume":"14","author":"Papageorgiou","year":"2025","journal-title":"J Clin Med"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/01616412.2025.2592857","article-title":"Adjunctive middle meningeal artery embolization for chronic subdural hematoma: a systematic review and meta-analysis of randomized controlled trials","author":"Shakir","year":"2025","journal-title":"Neurol Res"},{"key":"ref36","first-page":"737","article-title":"Efficacy and safety of middle meningeal artery embolization for patients with chronic subdural hematoma: a systematic review and meta-analysis","volume-title":"Cerebrovasc Dis","author":"Kabir","year":"2025"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1227\/neu.0000000000002369","article-title":"Middle meningeal artery embolization versus conventional management for patients with chronic subdural hematoma: a systematic review and meta-analysis","volume":"92","author":"Sattari","year":"2023","journal-title":"Neurosurgery"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1177\/15910199241263633","article-title":"Chronic subdural hematoma: what precisely are we treating?","volume":"32","author":"Qiao","year":"2024","journal-title":"Interv Neuroradiol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"196","DOI":"10.18071\/isz.77.0196","article-title":"Angiographic classification of chronic subdural hematoma","volume":"77","author":"Kupka","year":"2024","journal-title":"Ideggyogy Sz"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1366238","DOI":"10.3389\/fneur.2024.1366238","article-title":"Advances in chronic subdural hematoma and membrane imaging","volume":"15","author":"Chen","year":"2024","journal-title":"Front Neurol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1227\/neu.0000000000002038","article-title":"The \"bright falx\" sign\u2014midline embolic penetration is associated with faster resolution of chronic subdural hematoma after middle meningeal artery embolization: a case series","volume":"91","author":"Samarage","year":"2022","journal-title":"Neurosurgery"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"e222045","DOI":"10.1148\/radiol.222045","article-title":"Middle meningeal artery embolization for chronic subdural hematoma: predictors of clinical and radiographic failure from 636 embolizations","volume":"307","author":"Salem","year":"2023","journal-title":"Radiology"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1177\/15910199231217144","article-title":"Coil embolization alone appears sufficient for middle meningeal artery embolization","volume":"32","author":"Iyer","year":"2023","journal-title":"Interv Neuroradiol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"e581","DOI":"10.1016\/j.wneu.2022.06.099","article-title":"Middle meningeal artery embolization with isolated use of coils for treatment of chronic subdural hematomas: a case series","volume":"165","author":"Khorasanizadeh","year":"2022","journal-title":"World Neurosurg"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"104143","DOI":"10.1177\/1591019920982816","article-title":"Multidisciplinary consensus-based statement on the current role of middle meningeal artery embolization (MMAE) in chronic subdural hematoma (cSDH)","volume":"4","author":"Bartek","year":"2024","journal-title":"Brain Spine"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1161\/STROKEAHA.123.044129","article-title":"ARISE I consensus statement on the management of chronic subdural hematoma","volume":"55","author":"Kan","year":"2024","journal-title":"Stroke"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1259647","DOI":"10.3389\/fneur.2023.1259647","article-title":"Middle meningeal artery embolization for chronic subdural hematoma: a systematic review","volume":"14","author":"Omura","year":"2023","journal-title":"Front Neurol"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3174\/ajnr.A7796","article-title":"Embolic agent choice in middle meningeal artery embolization for chronic subdural hematoma","volume":"44","author":"Ku","year":"2023","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1007\/s00234-025-03634-y","article-title":"Material matters: a systematic review and meta-analysis of the effectiveness of different embolic agents in middle meningeal artery embolization","author":"Gupta","year":"2025","journal-title":"Neuroradiology"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1227\/neu.0000000000003218","article-title":"Embolic materials' comparison in meningeal artery embolization for chronic subdural hematomas: multicenter propensity score\u2013matched analysis of 1070 cases","volume":"96","author":"Salem","year":"2025","journal-title":"Neurosurgery"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1177\/1591019920982816","article-title":"Upfront middle meningeal artery embolization for treatment of chronic subdural hematomas in patients with or without midline shift","volume":"27","author":"Gomez-Paz","year":"2021","journal-title":"Interv Neuroradiol"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"102672","DOI":"10.1016\/j.bas.2023.102672","article-title":"A systematic review of middle meningeal artery embolization for minimally symptomatic chronic subdural haematomas that do not require immediate evacuation","volume":"3","author":"Rojas-Villabona","year":"2023","journal-title":"Brain Spine"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1177\/15910199241304852","article-title":"Middle meningeal artery embolization with standalone or adjunctive coiling for treatment of chronic subdural hematoma: systematic review and meta-analysis","volume":"32","author":"Hoffman","year":"2024","journal-title":"Interv Neuroradiol"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1161\/STROKEAHA.123.044129","article-title":"Extensive roles and technical advances of middle meningeal artery embolization for chronic subdural hematoma","volume":"63","author":"Nakagawa","year":"2023","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.bas.2024.104143","article-title":"Systematic review of current randomised control trials in chronic subdural haematoma and proposal for an international collaborative approach","volume":"162","author":"Edlmann","year":"2020","journal-title":"Acta Neurochir"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12968\/hmed.2025.0078","article-title":"Middle meningeal artery embolisation for chronic subdural haematoma\u2014time for a paradigm shift?","volume":"86","author":"Anderson","year":"2025","journal-title":"Br J Hosp Med (Lond)"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.12968\/hmed.2024.1015","article-title":"Safety and efficacy of atorvastatin for chronic subdural hematoma in Chinese patients: a randomized clinical trial","volume":"75","author":"Jiang","year":"2018","journal-title":"JAMA Neurol"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1056\/NEJMoa2020473","article-title":"Trial of dexamethasone for chronic subdural hematoma","volume":"383","author":"Hutchinson","year":"2020","journal-title":"N Engl J Med"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1177\/15910199241298727","article-title":"Bevacizumab: the future of chronic subdural hematoma","volume":"32","author":"Verma","year":"2024","journal-title":"Interv Neuroradiol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"218","DOI":"10.23736\/S0390-5616.25.06426-4","article-title":"Statins and middle meningeal artery embolization: a literature review in the treatment of chronic subdural hematoma","volume":"69","author":"Musmar","year":"2025","journal-title":"J Neurosurg Sci"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"109364","DOI":"10.12998\/wjcc.v13.i28.109364","article-title":"Middle meningeal artery embolisation in chronic subdural hematoma: a double-edged sword","volume":"13","author":"Morya","year":"2025","journal-title":"World J Clin Cases"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"e000906","DOI":"10.3389\/fneur.2023.1259647","article-title":"Middle meningeal artery embolization for chronic subdural hematoma: a review of established and emerging embolic agents","volume":"4","author":"Tudor","year":"2023","journal-title":"Stroke Vasc Interv Neurol"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"e001814","DOI":"10.1161\/SVIN.125.001814","article-title":"Consensus statement on middle meningeal artery embolization in chronic subdural hematoma treatment: a guideline from the society of vascular and interventional neurology guidelines and practice standards committee","volume":"5","author":"Siddiq","year":"2025","journal-title":"Stroke (Hoboken, NJ)"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1929416\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:46:29Z","timestamp":1787669189000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1929416\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":63,"alternative-id":["10.3389\/fneur.2026.1929416"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2026.1929416","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"article-number":"1929416"}}